Gidal, B. E., Maganti, R., Laurenza, A., Yang, H., Verbel, D. A., Schuck, E., & Ferry, J. (2017). Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters. Epilepsy research, 134, 41-48. https://doi.org/10.1016/j.eplepsyres.2017.04.018
Chicago Style (17th ed.) CitationGidal, Barry E., Rama Maganti, Antonio Laurenza, Haichen Yang, David A. Verbel, Edgar Schuck, and Jim Ferry. "Effect of Enzyme Inhibition on Perampanel Pharmacokinetics: Why Study Design Matters." Epilepsy Research 134 (2017): 41-48. https://doi.org/10.1016/j.eplepsyres.2017.04.018.
MLA (9th ed.) CitationGidal, Barry E., et al. "Effect of Enzyme Inhibition on Perampanel Pharmacokinetics: Why Study Design Matters." Epilepsy Research, vol. 134, 2017, pp. 41-48, https://doi.org/10.1016/j.eplepsyres.2017.04.018.